VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $2,438,000 | +4.8% | 153,200 | +36.8% | 0.04% | +23.5% |
Q4 2017 | $2,327,000 | +282.1% | 112,000 | +166.7% | 0.03% | +126.7% |
Q4 2016 | $609,000 | -82.8% | 42,000 | -70.9% | 0.02% | -87.2% |
Q3 2016 | $3,547,000 | -78.1% | 144,500 | -82.0% | 0.12% | -84.5% |
Q2 2016 | $16,186,000 | -37.3% | 803,700 | -18.1% | 0.76% | -39.5% |
Q1 2016 | $25,823,000 | +199.6% | 981,900 | +2162.4% | 1.25% | +50.7% |
Q1 2015 | $8,620,000 | +452.9% | 43,400 | +298.2% | 0.83% | +245.0% |
Q4 2014 | $1,559,000 | -32.9% | 10,900 | -38.4% | 0.24% | -46.4% |
Q3 2014 | $2,322,000 | +40.3% | 17,700 | +25.5% | 0.45% | +181.8% |
Q4 2013 | $1,655,000 | – | 14,100 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |